Franco Patrone

Immunology and Microbiology · Life Sciences

34h-index4.0kcitations232works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neutrophil, Myeloperoxidase and Oxidative Mechanisms(43), Chronic Lymphocytic Leukemia Research(20), Chronic Myeloid Leukemia Treatments(20), Immune Response and Inflammation(16), S100 Proteins and Annexins(15)

Publications231 total

Supplementary Figures legend from APO866 Increases Antitumor Activity of Cyclosporin-A by Inducing Mitochondrial and Endoplasmic Reticulum Stress in Leukemia Cells
2023Open Access
Supplementary Figures legend from APO866 Increases Antitumor Activity of Cyclosporin-A by Inducing Mitochondrial and Endoplasmic Reticulum Stress in Leukemia Cells
2023Open Access
Supplemental Figures 1-8 from APO866 Increases Antitumor Activity of Cyclosporin-A by Inducing Mitochondrial and Endoplasmic Reticulum Stress in Leukemia Cells
2023Open Access
Supplemental Figures 1-8 from APO866 Increases Antitumor Activity of Cyclosporin-A by Inducing Mitochondrial and Endoplasmic Reticulum Stress in Leukemia Cells
2023Open Access
Data from APO866 Increases Antitumor Activity of Cyclosporin-A by Inducing Mitochondrial and Endoplasmic Reticulum Stress in Leukemia Cells
2023Open Access
Data from APO866 Increases Antitumor Activity of Cyclosporin-A by Inducing Mitochondrial and Endoplasmic Reticulum Stress in Leukemia Cells
2023Open Access
Meet Our Editorial Board Member
Current Cancer Drug Targets·2018
Meet Our Editorial Board Member
Current Cancer Drug Targets·2018
Meet Our Editorial Board Member
Current Cancer Drug Targets·2017
mTORC1 and extracellular signal-regulated kinase (ERK1/2) inhibition
2017
Chylothorax as Rare Manifestation of Pleural Involvement in Waldenström Macroglobulinemia: Mechanisms and Management.
PubMed·2016· 4 cited
Systems medicine in colorectal cancer: from a mathematical model toward a new type of clinical trial
WIREs Systems Biology and Medicine·2016· 12 citedOpen Access
Transcription Factors Synergistically Activated at the Crossing of the Restriction Point between G1 and S Cell Cycle Phases. Pathologic Gate Opening during Multi-Hit Malignant Transformation
Nuclear Receptor Research·2016Open Access
Systems Medicine in Oncology: Signaling Network Modeling and New-Generation Decision-Support Systems
Methods in molecular biology·2015· 14 cited
APO866 Increases Antitumor Activity of Cyclosporin-A by Inducing Mitochondrial and Endoplasmic Reticulum Stress in Leukemia Cells
Clinical Cancer Research·2015· 39 citedOpen Access
Advances in dynamic modeling of colorectal cancer signaling-network regions, a path toward targeted therapies
Oncotarget·2014· 29 citedOpen Access
Sequential dose-dense 5-fluorouracil, epirubicin and cyclophosphamide followed by docetaxel in patients with early breast cancer with four or more positive lymph nodes.
PubMed·2014· 3 cited
Potentiation of crizotinib activity by fasting cycles in an ALK+ lung cancer model.
Journal of Clinical Oncology·2014· 4 cited
Role of genotype-based approach in the clinical management of adult acute myeloid leukemia with normal cytogenetics
Leukemia Research·2014· 41 cited
Sequential Dose-dense 5-fluorouracil, Epirubicin and Cyclophosphamide Followed by Docetaxel in Patients with Early Breast Cancer with Four or more Positive Lymph Nodes
Tumori Journal·2014· 3 cited
page 1 of 12Next →

Frequent Co-authors

Alessio Nencioni(32), Alberto Ballestrero(31), Michele Cea(17), Anna Garuti(15), Marco Gobbi(12), Peter Brossart(10), Franco Dallegri(10), Gabriele Zoppoli(9), Antonia Cagnetta(9), Eva Morán(8), Ilaria Rocco(8), Debora Soncini(7), Frank Grünebach(6), Santina Bruzzone(6), Gabriella Cirmena(6), Irene Caffa(5), Floriana Fruscione(5), Kenneth C. Anderson(5), Davide Boy(5), Mario Sessarego(5)